By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Novartis Pharma AG 

Lichtstrasse 35

Basel    CH-4002  Switzerland
Phone: 41-61-324-111 Fax: 41-61-324-8001




Beyond Genomics, Inc. 

Emisphere Technologies, Inc.  Salmon calcitonin

Company News
Proteus Digital Health, Inc. Grows Leadership Team And Board Of Directors With Former Executives From Novartis Pharma AG (NVS), Novartis Pharma AG (NVS) And Egreetings Network 4/16/2014 9:33:11 AM
Unigene Laboratories, Inc. (UGNE) Announces Novartis Pharma AG (NVS)' Disclosure of First Interpretable Results from Phase 3 Trial of Calcitonin (SMC021) in the Treatment of Post-menopausal Osteoporosis 11/14/2011 7:08:13 AM
Novartis Pharma AG (NVS) Selects Veeva Systems, Inc. CRM for Global Deployments 10/19/2010 10:41:35 AM
Emisphere Technologies, Inc. (EMIS), Novartis Pharma AG (NVS). Nordic Bioscience A/S Provide Update on Osteoarthritis Phase III Study With Oral Calcitonin; Drug Deemed Safe But Not Effective, Emisphere Stock Falls 61.15% at 1:37PM EDT 7/23/2010 7:08:08 AM
Emisphere Technologies, Inc. (EMIS) Announces Expanded Collaboration Agreement With Novartis Pharma AG (NVS) and Cancellation of Convertible Promissory Note 6/4/2010 9:58:37 AM
Titan Pharmaceuticals (TTP) Provides Estimate of Upcoming Royalty Payment 4/22/2010 10:51:38 AM
Emisphere Technologies, Inc. (EMIS) Partner Initiates Second Phase I Trial for Oral PTH Therapy for the Treatment of Postmenopausal Osteoporosis 4/15/2010 9:55:23 AM
Novartis Pharma AG (NVS) Reports Positive Results From Phase II LCZ696 Trial 3/17/2010 9:00:25 AM
Emisphere Technologies, Inc. (EMIS) Announces Extension of Maturity Date for Novartis Pharma AG (NVS) Convertible Promissory Note 11/30/2009 9:11:56 AM
Idenix Pharmaceuticals, Inc. (IDIX) Says Novartis Pharma AG (NVS) (JOBS) Not to License Hepatitis C Drug 10/30/2009 6:32:45 AM